Evidence map›Paper›PMID 35265640›Full record

ArticleFrontiers in medicine2022

Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages.

Fatima Mostefai, Isabel Gamache, Arnaud N'Guessan, Justin Pelletier, Jessie Huang, Carmen Lia Murall, Ahmad Pesaranghader, Vanda Gaonac'h-Lovejoy, David J Hamelin, Raphaël Poujol and 8 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Fatima MostefaiResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Isabel GamacheResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Arnaud N'GuessanResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Justin PelletierResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Jessie HuangDepartment of Computer Science, Yale University, New Haven, CT, United States.
Carmen Lia MurallDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Ahmad PesaranghaderMila - Quebec AI institute, Montreal, QC, Canada.
Vanda Gaonac'h-LovejoyDépartement de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.
David J HamelinResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Raphaël PoujolResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Jean-Christophe GrenierResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.
Martin SmithDépartement de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.
Etienne CaronResearch Centre, CHU Sainte-Justine, Montreal, QC, Canada.
Morgan CraigResearch Centre, CHU Sainte-Justine, Montreal, QC, Canada.
Guy WolfMila - Quebec AI institute, Montreal, QC, Canada.
Smita KrishnaswamyDepartment of Computer Science, Yale University, New Haven, CT, United States.
B Jesse ShapiroDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Julie G HussinResearch Centre, Montreal Heart Institute, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genome of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus disease 2019 (COVID-19), has been sequenced at an unprecedented scale leading to a tremendous amount of viral genome sequencing data. To assist in tracing infection pathways and design preventive strategies, a deep understanding of the viral genetic diversity landscape is needed. We present here a set of genomic surveillance tools from population genetics which can be used to better understand the evolution of this virus in humans. To illustrate the utility of this toolbox, we detail an in depth analysis of the genetic diversity of SARS-CoV-2 in first year of the COVID-19 pandemic. We analyzed 329,854 high-quality consensus sequences published in the GISAID database during the pre-vaccination phase. We demonstrate that, compared to standard phylogenetic approaches, haplotype networks can be computed efficiently on much larger datasets. This approach enables real-time lineage identification, a clear description of the relationship between variants of concern, and efficient detection of recurrent mutations. Furthermore, time series change of Tajima's D by haplotype provides a powerful metric of lineage expansion. Finally, principal component analysis (PCA) highlights key steps in variant emergence and facilitates the visualization of genomic variation in the context of SARS-CoV-2 diversity. The computational framework presented here is simple to implement and insightful for real-time genomic surveillance of SARS-CoV-2 and could be applied to any pathogen that threatens the health of populations of humans and other organisms.

Indexed as

haplotype networklineage annotationpopulation genomicsprincipal component analysisSARS-CoV-2variant detectionviral surveillance

Identifiers

PMID35265640
PMCPMC8899026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.